...
首页> 外文期刊>Cell transplantation >beta B2-Crystallin Promotes Axonal Regeneration in the Injured Optic Nerve in Adult Rats
【24h】

beta B2-Crystallin Promotes Axonal Regeneration in the Injured Optic Nerve in Adult Rats

机译:beta B2-Crystallin促进成年大鼠受伤视神经轴突再生

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of the study was to further scrutinize the potential of beta B2-crystallin in supporting regeneration of injured retinal ganglion cell axons both in vitro and in vivo. Retinal explants obtained from animals after treatment either with lens injury (LI) alone or with combined LI 5 days or 3 days before or simultaneously with an optic nerve crush (ONC) were cultured for 96 h under regenerative conditions, and the regenerating axons were quantified and compared with untreated controls. These measurements were then repeated with LI replaced by intravitreal injections of y-crystallin and p-crystallin at 5 days before ONC. Finally, 332-crystallin-overexpressing transfected neural progenitor cells (beta B2-crystallin-NPCs) in the eye were studied after crushing the optic nerve in vivo. Regeneration was monitored with the aid of immunoblotting of the retina and optic nerve both distal and proximal to the lesion site, and this was compared with controls that received injections of phosphate buffer only. LI performed 5 days or 3 days before ONC significantly promoted axonal outgrowth in vitro (p<0.001), while LI performed alone before explantation did not. Intravitreal injections of beta-crystallin and gamma-crystallin mimicked the effects of LI and significantly increased axonal regeneration in culture at the same time intervals (p<0.001). Western blot analysis revealed that crystallins were present in the proximal optic nerve stump at the lesion site in ONC, but were neither expressed in the undamaged distal optic nerve nor in uninjured tissue. beta B2-crystallin-NPCs supported the regeneration of cut optic nerve axons within the distal optic nerve stump in vivo. The reported data suggest that beta B2-crystallin-producing "cell factories" could be used to provide novel therapeutic drugs for central nervous system injuries.
机译:该研究的目的是进一步研究βB2-晶状蛋白在体内和体外支持受损的视网膜神经节细胞轴突再生的潜力。在再生条件下,从单独使用晶状体损伤(LI)或在合并视神经压迫(ONC)前5天或3天或同时使用LI联合处理后的动物中提取的视网膜外植体培养96小时,并对再生轴突进行定量并与未处理的对照组进行比较。然后,在ONC前5天,用玻璃体内注射y-晶状体蛋白和p-晶状体蛋白代替LI重复这些测量。最后,在体内压伤视神经后,研究了眼中332过度表达结晶蛋白的转染神经祖细胞(βB2-结晶蛋白-NPC)。借助于在病变部位远端和近端的视网膜和视神经的免疫印迹监测再生,并将其与仅接受磷酸盐缓冲液注射的对照组进行比较。在ONC显着促进体外轴突生长之前5天或3天进行LI手术(p <0.001),而在移植前单独进行LI则没有。玻璃体内注射β-晶状体蛋白和γ-晶状体蛋白可模仿LI的作用,并在相同的时间间隔内显着增加培养物中的轴突再生(p <0.001)。蛋白质印迹分析表明,晶状体蛋白存在于ONC病变部位的近视神经残端,但在未受损的远端视神经和未损伤的组织中均未表达。 βB2-crystallin-NPC支持体内远端视神经残端内视神经轴突的再生。报道的数据表明,产生βB2晶体蛋白的“细胞工厂”可用于为中枢神经系统损伤提供新型治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号